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A saving grace of the COVID-19 pandemic 
in high- income and upper middle- income 
countries has been the relative sparing 
of children. As the disease spreads across 
low- income and middle- income countries 
(LMICs), long- standing system vulnerabil-
ities may tragically manifest, and we worry 
that children will be increasingly impacted, 
both directly and indirectly. Drawing on our 
shared child pneumonia experience glob-
ally, we highlight these potential impacts on 
children in LMICs and propose actions for a 
collective response.
Current data suggest children are suscep-
tible to severe acute respiratory syndrome 
coronavirus 2 (SARS- CoV-2) infection but 
are less likely than adults to become severely 
ill.1–4 Although at first glance these data 
appear reassuring, the child pneumonia, 
and broader global child health, experi-
ence provides a forewarning of what may be 
coming in LMICs. High- income countries 
(HICs) have an under-5 pneumonia mortality 
rate of 3 per 100 000.5 In contrast, the rate 
in LMICs is 200 per 100 000 population, with 
pneumonia the leading infectious cause of 
under-5 death globally.5 While yet unknown, 
COVID-19, a viral pneumonia syndrome, may 
impact children in LMICs more severely than 
what has been observed to date.
The risk factors for poor outcomes in 
pneumonia are overwhelmingly more prev-
alent in LMICs than HICs. These include 
severe malnutrition, low immunisation 
uptake, nutritional anaemia, HIV expo-
sure or infection, air pollution, poverty, low 
parental education and, crucially, limited 
access to high- quality acute healthcare.6 7 In 
HICs, vulnerable children are being actively 
‘shielded’ from infection, but in LMICs, 
most will remain exposed.
The indirect effects of the COVID-19 
response need attention as they are an enor-
mous threat to the well- being of children. 
These include widespread parental unem-
ployment, disrupted education, food and 
housing insecurity and threats to vital preven-
tive health programmes, like immunisation, 
antenatal care, infant feeding and mental 
health. The acute care workforce may soon 
be overwhelmed by COVID-19 needs, and we 
anticipate critical healthcare services being 
diverted away from mothers and children. 
Delays in care seeking may worsen, resulting 
in more severe illness. So, while transmis-
sion of respiratory pathogens may be slowed 
by pandemic response measures, these 
measures could accentuate well- established 
risk factors for poor paediatric outcomes and 
undermine healthcare systems’ abilities to 
respond.









ealth: first published as 10.1136/bm





2 Ahmed S, et al. BMJ Global Health 2020;5:e002844. doi:10.1136/bmjgh-2020-002844
BMJ Global Health
What can be done to protect children in LMICs? 
First, we must prevent the collapse of vital acute care 
(oxygen, antibiotics, personal protective equipment 
(PPE)), preventive services (immunisation, maternity 
care, breastfeeding and nutrition programmes, HIV and 
malaria prevention) and supply chains and take oppor-
tunities for system strengthening that could be a legacy 
of the pandemic. Maintaining a critical workforce in 
maternal and child health, enabling healthcare workers 
to use PPE and empowering community health workers 
to engage with communities in the response are essential. 
These measures, taken locally with decisive international 
support, are likely to save more children’s lives than 
advanced intensive care and should benefit children with 
COVID-19 and other illnesses, including pneumonia.
Second, COVID-19 testing in LMICs needs massive 
upscaling and outreach. If we are to understand paedi-
atric COVID-19, surveillance systems—both pandemic 
and pneumonia focused—need investment for rapid 
scale- up and testing of children with respiratory illnesses 
for SARS- CoV-2, testing paediatric contacts of adult cases 
and accurately reporting child deaths.
Third, pandemic lockdown strategies should main-
tain vital access to care and be tailored to the partic-
ular social, economic and health environments of 
LMICs. This may not mean following the approach of 
HICs. Rather, LMICs should also build on their expe-
rience and expertise gained during other epidemics 
and make decisions based on their reality, workforce 
capacity, population density and migration patterns. 
Examples could be establishing separate areas in clinics 
for preventative care by dedicated non- respiratory 
staff, home vaccination visits, outposts responsible for 
delivery of household essentials to COVID-19 affected 
households, retraining newly unemployed people to 
assist with case finding and contact tracing and sewing 
groups to produce face masks to support widespread 
mask strategies.
Fourth, research is key to better understanding 
COVID-19 fundamentals on children, younger and 
older, including their role in transmission dynamics, 
spectrum of illness and outcomes, the impact of 
comorbidities and common coinfections (viral, bacte-
rial, mycobacterial and parasitic) and how broader 
pandemic responses impact on health behaviours 
and outcomes. To accomplish this requires COVID-19 
surveillance and rapid cycle research on the effects of 
pandemic response strategies and context- informed 
modelling using the best available data and locally 
relevant assumptions. Understanding COVID-19 in 
children is essential to developing informed, nuanced 
pandemic responses, including eventual vaccina-
tion strategies. These efforts must be country- driven, 
network- building, joint global initiatives supported by 
the international community for the benefit of all.
We expect children in LMICs may be seriously 
impacted by COVID-19, potentially both directly and 
indirectly. Balanced strategies that protect children 
must be central to coordinated and cooperative global 
pandemic response efforts.
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